89 related articles for article (PubMed ID: 2081205)
21. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
Villar HE; Jugo MB; Fernández-Lausi A; Farinati AE
Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
[TBL] [Abstract][Full Text] [Related]
22. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
Hardin TC; Butler SC; Ross S; Wakeford JH; Jorgensen JH
Pharmacotherapy; 1994; 14(2):147-52. PubMed ID: 8197032
[TBL] [Abstract][Full Text] [Related]
23. [A simple enzyme assay for the simultaneous determination of penicillin derivatives and clavulanic acid in biological fluids].
Cullmann W; Dick W
Immun Infekt; 1986 Sep; 14(5):188-90. PubMed ID: 3533762
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate.
Ferslew KE; Daigneault EA; Aten EM; Roseman JM
J Clin Pharmacol; 1984 Oct; 24(10):452-6. PubMed ID: 6511988
[TBL] [Abstract][Full Text] [Related]
25. The effects of three beta-lactamase inhibitors: YTR830H, sulbactam and clavulanic acid on the growth of human cells in culture.
Yamabe S; Adachi K; Watanabe M; Ueda S
Chemioterapia; 1987 Oct; 6(5):337-40. PubMed ID: 2827899
[TBL] [Abstract][Full Text] [Related]
26. The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis.
Farmer TH; Reading C
J Antimicrob Chemother; 1988 Aug; 22(2):105-11. PubMed ID: 3263350
[TBL] [Abstract][Full Text] [Related]
27. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
[TBL] [Abstract][Full Text] [Related]
28. An enzymatic method for assaying sulbactam in human serum: comparison with high performance liquid chromatography.
Sotto A; Peray P; Geny F; Brunschwig C; Carrière C; Galtier M; Ramuz M; Jourdan J
J Antimicrob Chemother; 1995 Mar; 35(3):429-33. PubMed ID: 7782260
[TBL] [Abstract][Full Text] [Related]
29. The pharmacokinetics of sultamicillin.
Lode H; Hampel B; Bruckner G; Koeppe P
APMIS Suppl; 1989; 5():17-22. PubMed ID: 2660866
[TBL] [Abstract][Full Text] [Related]
30. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
[TBL] [Abstract][Full Text] [Related]
31. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Piddock LJ; Jin YF; Turner HL
J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
[TBL] [Abstract][Full Text] [Related]
32. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
Gill CJ; Ponticas S; Shungu DL; Guerriero S
Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
Moittie D; Simonet M; Veron M
Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
35. Assay of amoxicillin and clavulanic acid, the components of Augmentin, in biological fluids with high-performance liquid chromatography.
Foulstone M; Reading C
Antimicrob Agents Chemother; 1982 Nov; 22(5):753-62. PubMed ID: 7181486
[TBL] [Abstract][Full Text] [Related]
36. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Chin NX; McElrath MJ; Neu HC
Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
[TBL] [Abstract][Full Text] [Related]
37. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
Aldridge KE; Sanders CV; Marier RL
J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
[TBL] [Abstract][Full Text] [Related]
38. [Kinetics of serum activity of beta-lactamases inhibitors. Development of a biologic assay].
Sotto A; Carrière C; Carles MJ; Ramuz M; Jourdan J
Pathol Biol (Paris); 1991 Feb; 39(2):147-9. PubMed ID: 2017339
[No Abstract] [Full Text] [Related]
39. Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests?
Greenwood D
J Antimicrob Chemother; 1996 Jul; 38(1):17-20. PubMed ID: 8858452
[No Abstract] [Full Text] [Related]
40. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
